News & Perspective

Dec 04, 2014

Dec 04, 2014
Vaccine in arm

Groups report early safety data, progress on Ebola vaccines

Several early vaccine trials are under way, and another American is airlifted home.

Nov 24, 2014

Nov 24, 2014
Ebola vaccine shot

NewLink, Merck deal boosts prospects for Ebola vaccine

The small biotech and the drug giant announced an agreement today.

Jan 23, 2013

Jan 23, 2013

Research moratorium on modified H5N1 viruses ends

(CIDRAP News) – A year-long voluntary moratorium on research involving transmissible H5N1 avian flu viruses ended today with a letter from a group of scientists that supports resuming the work in countries that have addressed the biosafety issues involved.

Oct 09, 2012

Oct 09, 2012

Experts ponder H5N1 research moratorium issues

(CIDRAP News) – The moratorium on research leading to more-transmissible H5N1 avian influenza viruses, originally set for 60 days, has remained in place for 8 months without a clear end in sight, but a series of commentaries in mBio today from experts familiar with the issues offers some clues for possible next steps.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»